RVMD insider sale notice: Mancini sold 43,691 shares

Revolution Medicines (RVMD) Rule 144 sale notice reporting insider dispositions.

Rhea-AI Filing Summary

Revolution Medicines (RVMD) Rule 144 sale notice reporting insider dispositions. The filing lists recent open‑market sales of Common Stock by Anthony Mancini: 37,450 shares on 03/25/2026, 3,120 shares on 04/27/2026, and 3,121 shares on 05/26/2026, each with an associated dollar amount. The filing also shows a restricted stock unit grant dated 04/01/2025 for 4,211 shares tied to services rendered. Shares outstanding are listed as 212,596,462 as of 06/15/2026 in the provided excerpt.

Insights

Securities Counsel

Rule 144 notice documents recent insider dispositions and a prior RSU grant.

The excerpt lists three dispositions by Anthony Mancini with explicit share counts and dollar amounts for each transaction and a prior restricted stock unit grant of 4,211 shares dated 04/01/2025. These entries are procedural notices that report sales under Rule 144.

The primary dependency is compliance with Rule 144 resale conditions; timing, holding periods, and any volume limitations are not detailed in the excerpt. Subsequent filings or transaction confirmations would be needed to verify trading method and compliance specifics.

Key Figures

Sale - 03/25/2026: 37,450 shares Proceeds - 03/25/2026: 3,578,823.12 Sale - 04/27/2026: 3,120 shares +5 more

8 metrics

Sale - 03/25/2026 37,450 shares sale reported on 03/25/2026

Proceeds - 03/25/2026 3,578,823.12 dollar figure adjacent to 37,450 shares in excerpt

Sale - 04/27/2026 3,120 shares sale reported on 04/27/2026

Proceeds - 04/27/2026 413,128.87 dollar figure adjacent to 3,120 shares in excerpt

Sale - 05/26/2026 3,121 shares sale reported on 05/26/2026

Proceeds - 05/26/2026 480,610.90 dollar figure adjacent to 3,121 shares in excerpt

RSU grant 4,211 shares restricted stock unit grant dated 04/01/2025

Shares outstanding 212,596,462 shares listed as of 06/15/2026 in excerpt header

Key Terms

restricted stock unit grant, Common Stock, Form 144

3 terms

restricted stock unit grant financial

"Common Stock | 04/01/2025 | Restricted stock unit grant"

Common Stock financial

"Securities Sold During The Past 3 Months | Common Stock | 03/25/2026"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What sales does the RVMD Form 144 report for Anthony Mancini?

The filing reports three sales: 37,450 shares on 03/25/2026, 3,120 shares on 04/27/2026, and 3,121 shares on 05/26/2026. Each sale entry in the excerpt includes an associated dollar amount beside the share count.

Does the filing show any grants or issuances for RVMD related to these shares?

Yes. The excerpt lists a restricted stock unit grant dated 04/01/2025 for 4,211 shares attributed to services rendered and issued by the issuer. The grant date and share count are shown in the securities section.

What total outstanding share figure is included in the provided RVMD excerpt?

The excerpt includes a shares outstanding figure of 212,596,462 as of 06/15/2026. This number appears in the filing header area of the provided content and is presented with that date.

Are proceeds or dollar amounts shown for the reported sales in the RVMD excerpt?

Yes. Each reported sale row includes a numeric dollar figure next to the share count: 3,578,823.12 for 37,450 shares, 413,128.87 for 3,120 shares, and 480,610.90 for 3,121 shares, as shown in the excerpt.

Does the excerpt state how the sales were executed or any resale restrictions?

The provided excerpt does not specify execution method or resale restrictions. It lists sale dates, share counts, and dollar amounts but contains no description of trade method, broker, or conditional resale language in the visible text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 06:07 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002124509
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Revolution Medicines, Inc.
SEC File Number	001-39219
Address of Issuer	700 SAGINAW DR REDWOOD CITY CALIFORNIA 94063
Phone	650-481-6801
Name of Person for Whose Account the Securities are To Be Sold	Mancini Anthony
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	ETRADE Financial Corporation 3 Edison Drive Alpharetta GA 30005	4211	647946.57	212596462	06/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/01/2025	Restricted stock unit grant	Issuer			4211	04/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Anthony Mancini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	03/25/2026	37450	3578823.12
Anthony Mancini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	04/27/2026	3120	413128.87
Anthony Mancini c/o Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	Common Stock	05/26/2026	3121	480610.90

144: Remarks and Signature

Remarks
Date of Notice	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Jack Anders, as Attorney-in-fact for Anthony Mancini
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)